| Case fatality rate of cancer patients with COVID-19 in a New York hospital system V Mehta, S Goel, R Kabarriti, D Cole, M Goldfinger, A Acuna-Villaorduna, ... Cancer discovery 10 (7), 935-941, 2020 | 800 | 2020 |
| Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials N Ohri, X Shen, AP Dicker, LA Doyle, AS Harrison, TN Showalter Journal of the National Cancer Institute 105 (6), 387-393, 2013 | 298 | 2013 |
| What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom M Werner-Wasik, AD Nelson, W Choi, Y Arai, PF Faulhaber, P Kang, ... International Journal of Radiation Oncology* Biology* Physics 82 (3), 1164-1171, 2012 | 229 | 2012 |
| Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling N Ohri, AP Dicker, EJ Trabulsi, TN Showalter European Journal of Cancer 48 (6), 837-844, 2012 | 183 | 2012 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 173 | 2021 |
| Local control after stereotactic body radiation therapy for liver tumors N Ohri, WA Tomé, AM Romero, M Miften, RK Ten Haken, LA Dawson, ... International Journal of Radiation Oncology* Biology* Physics 110 (1), 188-195, 2021 | 170 | 2021 |
| Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry DC Hood, P Thienprasiddhi, VC Greenstein, BJ Winn, N Ohri, ... Investigative ophthalmology & visual science 45 (2), 492-498, 2004 | 146 | 2004 |
| Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020; 10 (7): 935–941. doi: 10.1158/2159-8290 V Mehta, S Goel, R Kabarriti, D Cole, M Goldfinger, A Acuna-Villaorduna, ... CD-20-0516.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 142 | |
| Late toxicity rates following definitive radiotherapy for prostate cancer N Ohri, AP Dicker, TN Showalter The Canadian journal of urology 19 (4), 6373, 2012 | 106 | 2012 |
| Radiotherapy for hepatocellular carcinoma: new indications and directions for future study N Ohri, LA Dawson, S Krishnan, J Seong, JC Cheng, SK Sarin, ... JNCI: Journal of the National Cancer Institute 108 (9), djw133, 2016 | 99 | 2016 |
| Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center N Ohri, BD Rapkin, C Guha, S Kalnicki, M Garg International Journal of Radiation Oncology* Biology* Physics 95 (2), 563-570, 2016 | 97 | 2016 |
| Pretreatment 18F-FDG PET textural features in locally advanced non–small cell lung cancer: secondary analysis of ACRIN 6668/RTOG 0235 N Ohri, F Duan, BS Snyder, B Wei, M Machtay, A Alavi, BA Siegel, ... Journal of Nuclear Medicine 57 (6), 842-848, 2016 | 94 | 2016 |
| Systematic review of hypofractionated radiation therapy for prostate cancer NG Zaorsky, N Ohri, TN Showalter, AP Dicker, RB Den Cancer treatment reviews 39 (7), 728-736, 2013 | 90 | 2013 |
| Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis N Ohri, MK Garg, S Aparo, A Kaubisch, W Tome, TJ Kennedy, S Kalnicki, ... International Journal of Radiation Oncology* Biology* Physics 86 (2), 330-335, 2013 | 86 | 2013 |
| Radiation dose‐volume effects for liver SBRT M Miften, Y Vinogradskiy, V Moiseenko, J Grimm, E Yorke, A Jackson, ... International Journal of Radiation Oncology* Biology* Physics 110 (1), 196-205, 2021 | 85 | 2021 |
| Pretreatment FDG-PET metrics in stage III non–small cell lung cancer: ACRIN 6668/RTOG 0235 N Ohri, F Duan, M Machtay, JJ Gorelick, BS Snyder, A Alavi, BA Siegel, ... Journal of the National Cancer Institute 107 (4), djv004, 2015 | 80 | 2015 |
| Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group N Ohri, M Werner-Wasik, IS Grills, J Belderbos, A Hope, D Yan, LL Kestin, ... International Journal of Radiation Oncology* Biology* Physics 84 (3), e379-e384, 2012 | 73 | 2012 |
| Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma: clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography H Eldredge-Hindy, N Ohri, PR Anne, D Eschelman, C Gonsalves, ... American journal of clinical oncology 39 (2), 189-195, 2016 | 67 | 2016 |
| Predictors of radiation therapy noncompliance in an urban academic cancer center N Ohri, BD Rapkin, D Guha, H Haynes-Lewis, C Guha, S Kalnicki, M Garg International Journal of Radiation Oncology* Biology* Physics 91 (1), 232-238, 2015 | 66 | 2015 |
| The impact of COVID-19 on radiation oncology clinics and patients with cancer in the United States A Rivera, N Ohri, E Thomas, R Miller, MA Knoll Advances in radiation oncology 5 (4), 538-543, 2020 | 65 | 2020 |
Wolfgang A. ToméProfessor, Albert Einstein College of Medicine在 einsteinmed.edu 的电子邮件经过验证
